Workflow
亚泰集团(600881) - 2024 Q1 - 季度财报
YTGYTG(SH:600881)2024-04-29 11:57

Financial Performance - The company's operating revenue for Q1 2024 was CNY 1,000,650,375.76, representing a decrease of 37.79% compared to the same period last year[5]. - The net profit attributable to shareholders was CNY -515,915,343.05, a decline of 50.65% year-over-year[5]. - Basic earnings per share were CNY -0.16, down 45.45% from the same period last year[6]. - Total operating revenue for Q1 2024 was CNY 1,000,650,375.76, a decrease of 37.8% compared to CNY 1,608,455,332.98 in Q1 2023[24]. - The net loss for Q1 2024 was ¥643.56 million, compared to a net loss of ¥465.28 million in Q1 2023, representing a 38.3% increase in losses year-over-year[25]. - The company reported a total comprehensive loss of ¥637.23 million for Q1 2024, compared to a loss of ¥464.62 million in the same period last year[25]. Cash Flow and Assets - The net cash flow from operating activities was CNY -282,442,386.93, reflecting a decrease of 117.68% compared to the previous year[8]. - Cash and cash equivalents decreased to CNY 494,796,063.11 in Q1 2024 from CNY 515,687,210.24 in Q1 2023[20]. - The operating cash flow for Q1 2024 was negative at ¥282.44 million, a significant decline from a positive cash flow of ¥1.60 billion in Q1 2023[28]. - Cash and cash equivalents at the end of Q1 2024 increased to ¥234.19 million from ¥183.48 million at the end of Q1 2023, marking a 27.6% increase[29]. Liabilities and Equity - Total liabilities increased to CNY 39,377,116,466.37 in Q1 2024 from CNY 38,597,689,411.15 in Q1 2023[20]. - The total liabilities increased to ¥13.87 billion in Q1 2024, up from ¥12.66 billion in Q1 2023, reflecting a growth of 9.5%[29]. - The equity attributable to shareholders decreased by 8.81% to CNY 5,251,175,188.77 compared to the end of the previous year[6]. Operating Costs and Expenses - Total operating costs for Q1 2024 were CNY 1,700,488,725.15, down 23.1% from CNY 2,211,302,665.41 in Q1 2023[24]. - The company incurred operating expenses of approximately ¥2.04 billion in Q1 2024, down from ¥2.45 billion in Q1 2023, indicating a 16.8% reduction[28]. - Research and development expenses for Q1 2024 were CNY 12,238,232.70, a decrease of 26.6% from CNY 16,608,411.20 in Q1 2023[24]. Shareholder Information - The company had a total of 101,319 common shareholders at the end of the reporting period[10]. - The top shareholder, Changchun Municipal Government State-owned Assets Supervision and Administration Commission, holds 9.08% of the shares[10]. Investments and Subsidiaries - The company plans to sell 20.81% of its stake in Northeast Securities to Changchun Urban Development Investment Holdings (Group) Co., Ltd., and 9% to Changchun Financial Holdings Group Co., Ltd. or its designated subsidiaries[11]. - The company has authorized the sale of Jinta Vineyards & Winery, LLC's assets, including inventory and fixed assets, with a minimum listing price of USD 2,014,000[13]. - Four wholly-owned subsidiaries of Jilin Yatai Pharmacy Co., Ltd. have been established, each with a registered capital of RMB 500,000[14]. - The company received an initial payment of RMB 84 million for the transfer of equity in Jiangsu Weikail Medical Technology Co., Ltd. before December 31, 2023[14]. - The company completed a capital increase of RMB 13,765,800 for Jilin Yatai Run De Construction Co., Ltd., resulting in a 40.8% ownership stake[14]. - The company has initiated the registration process for the newly established subsidiaries, which has been completed as of April 2024[15]. Asset Valuation - Total assets at the end of the reporting period were CNY 45,705,410,080.01, an increase of 0.32% from the end of the previous year[6]. - As of March 31, 2024, the company's total current assets amounted to RMB 21,005,545,660.42, an increase from RMB 20,701,583,311.60 as of December 31, 2023, reflecting a growth of approximately 1.47%[18]. - As of March 31, 2024, long-term equity investments were valued at RMB 10,287,739,837.35, slightly up from RMB 10,229,505,065.74 as of December 31, 2023[18].